PHILADELPHIA, March 12 /PRNewswire/ -- ERT, a leading provider of centralized ECG and eClinical technology, ePRO, and other services to the biopharmaceutical, medical device, and related industries, announced today that it will be showcasing its portfolio of products and services on Booth #1253/1254 at the 21st Annual DIA Euromeeting, 23-25 March 2009 in Berlin, Germany. ERT is also inviting attendees to three speaking sessions, which will discuss the impact of technology and standards on drug delivery.
Following a successful company rebranding exercise, ERT has unveiled four new sub-brands of its industry-leading products and services, including ERT Cardiac Safety Solutions, ERT EDC Solutions, ERT ePRO Solutions, and ERT Clinical Research Consulting Group. ERT representatives will be on booth at the DIA Euromeeting to discuss the Company's latest innovations, as well as the latest advancements within the industry.
In addition, ERT will be taking part in three presentations at the Euromeeting under the conference track, The Impact of Technology and Standards on Drug Development: Now Better, Safer and Faster. The first talk, entitled "The Loose Ends in EDC and How to Address Them," will be held on 24 March between 4:00 pm - 5:30 pm. The second session - "A Look into the Future: What is on the Horizon After We Have Managed EDC Properly?" - will be held from 9:00 am to 10:30 am, on 25 March. The final session will also be held on 25 March between 2:00 pm - 3:30 pm entitled "CDISC end-to-end: To What Extent Do the CDISC Standards Achieve Information System Independence?"
DIA's 21st Annual Euromeeting attracts more than 3,000 professionals from over 50 countries. It brings together representatives from the biopharmaceutical industry, contract service organizations, academic research centers, regulatory agencies, health ministries, patients' organizations and trade associations. More than 240 exhibitors will be
Copyright©2009 PR Newswire.
All rights reserved